LYME VACCINE HUMANS

Brand Owner (click to sort) Address Description
ACTICINE CONNAUGHT TECHNOLOGY CORPORATION 3711 Kennett Pike, Suite 200 Greenville DE 19807 lyme vaccine for humans;ACT VACCINE;
ACTICINE CONNAUGHT TECHNOLOGY CORPORATION 3711 Kennett Pike, Suite 200 Greenville DE 19807 LYME VACCINE FOR HUMANS TO BE ADMINISTRATED BY MEDICAL PROFESSIONALS;
ACTICINE CONNAUGHT TECHNOLOGY CORPORATION 3711 Kennett Pike, Suite 200 Greenville DE 19807 LYME VACCINE FOR HUMANS;
ELYMIT CONNAUGHT TECHNOLOGY CORPORATION 3711 Kennett Pike, Suite 200 Greenville DE 19807 lyme vaccine for humans;
IMULYME CONNAUGHT TECHNOLOGY CORPORATION 3711 Kennett Pike, Suite 200 Greenville DE 19807 lyme vaccine for humans;IMMUNE LYME;
IMULYME CONNAUGHT TECHNOLOGY CORPORATION 3711 Kennett Pike, Suite 200 Greenville DE 19807 LYME VACCINE FOR HUMANS;
IMULYME CONNAUGHT TECHNOLOGY CORPORATION 3711 Kennett Pike, Suite 200 Greenville DE 19807 LYME VACCINE FOR HUMANS;
INHIBIT CONNAUGHT TECHNOLOGY CORPORATION 3711 Kennett Pike, Suite 200 Greenville DE 19807 lyme vaccine for humans;
INHIBIT CONNAUGHT TECHNOLOGY CORPORATION 3711 Kennett Pike, Suite 200 Greenville DE 19807 LYME VACCINE FOR HUMANS;
INNOCULYME CONNAUGHT TECHNOLOGY CORPORATION 3711 Kennett Pike, Suite 200 Greenville DE 19807 lyme vaccine for humans;
INNOCULYME CONNAUGHT TECHNOLOGY CORPORATION 3711 Kennett Pike, Suite 200 Greenville DE 19807 LYME VACCINE FOR HUMANS;
LYM-MED CONNAUGHT TECHNOLOGY CORPORATION 3711 Kennett Pike, Suite 200 Greenville DE 19807 lyme vaccine for humans;
LYMAC CONNAUGHT TECHNOLOGY CORPORATION 3711 Kennett Pike, Suite 200 Greenville DE 19807 lyme vaccine for humans;
LYMACT CONNAUGHT TECHNOLOGY CORPORATION 3711 Kennett Pike, Suite 200 Greenville DE 19807 lyme vaccine for humans;LYME ACT;
LYMACT CONNAUGHT TECHNOLOGY CORPORATION 3711 Kennett Pike, Suite 200 Greenville DE 19807 LYME VACCINE FOR HUMANS;LIME ACT;
LYMACTIN CONNAUGHT TECHNOLOGY CORPORATION 3711 Kennett Pike, Suite 200 Greenville DE 19807 lyme vaccine for humans;
LYMACTIN CONNAUGHT TECHNOLOGY CORPORATION 3711 Kennett Pike, Suite 200 Greenville DE 19807 LYME VACCINE FOR HUMANS;
LYMACTIVE CONNAUGHT TECHNOLOGY CORPORATION 3711 Kennett Pike, Suite 200 Greenville DE 19807 lyme vaccine for humans;LYME ACTIVE;
LYMACTIVE CONNAUGHT TECHNOLOGY CORPORATION 3711 Kennett Pike, Suite 200 Greenville DE 19807 LYME VACCINE FOR HUMANS;LIME ACTIVE;
LYMCINE CONNAUGHT TECHNOLOGY CORPORATION 3711 Kennett Pike, Suite 200 Greenville DE 19807 lyme vaccine for humans;LYME VACCINE;
LYME IMMUNE CONNAUGHT TECHNOLOGY CORPORATION 3711 Kennett Pike, Suite 200 Greenville DE 19807 Lyme vaccine for humans;
LYMECINE CONNAUGHT TECHNOLOGY CORPORATION 3711 Kennett Pike, Suite 200 Greenville DE 19807 lyme vaccine for humans;
LYMED CONNAUGHT TECHNOLOGY CORPORATION 3711 Kennett Pike, Suite 200 Greenville DE 19807 lyme vaccine for humans;
LYMEDEFEND CONNAUGHT TECHNOLOGY CORPORATION 3711 Kennett Pike, Suite 200 Greenville DE 19807 lyme vaccine for humans;
LYMEDEFEND CONNAUGHT TECHNOLOGY CORPORATION 3711 Kennett Pike, Suite 200 Greenville DE 19807 LYME VACCINE FOR HUMANS;
LYMEGEN CONNAUGHT TECHNOLOGY CORPORATION 3711 Kennett Pike, Suite 200 Greenville DE 19807 lyme vaccine for humans;
LYMEGEN CONNAUGHT TECHNOLOGY CORPORATION 3711 Kennett Pike, Suite 200 Greenville DE 19807 LYME VACCINE FOR HUMANS;
LYMEGUARD CONNAUGHT TECHNOLOGY CORPORATION 3711 Kennett Pike, Suite 200 Greenville DE 19807 lyme vaccine for humans;LYME GUARD;
LYMEGUARD CONNAUGHT TECHNOLOGY CORPORATION 3711 Kennett Pike, Suite 200 Greenville DE 19807 LYME VACCINE FOR HUMANS;LYME GUARD;
LYMEHIBIT CONNAUGHT TECHNOLOGY CORPORATION 3711 Kennett Pike, Suite 200 Greenville DE 19807 lyme vaccine for humans;
LYMEIMMUNE CONNAUGHT TECHNOLOGY CORPORATION 3711 Kennett Pike, Suite 200 Greenville DE 19807 lyme vaccine for humans;LYME IMMUNE;
LYMEIMMUNE CONNAUGHT TECHNOLOGY CORPORATION 3711 Kennett Pike, Suite 200 Greenville DE 19807 LYME VACCINE FOR HUMANS;LYME IMMUNE;
LYMESHIELD CONNAUGHT TECHNOLOGY CORPORATION 3711 Kennett Pike, Suite 200 Greenville DE 19807 lyme vaccine for humans;LYME SHIELD;
LYMESHIELD CONNAUGHT TECHNOLOGY CORPORATION 3711 Kennett Pike, Suite 200 Greenville DE 19807 LYME VACCINE FOR HUMANS;LYME SHIELD;
LYMEX CONNAUGHT TECHNOLOGY CORPORATION 3711 Kennett Pike, Suite 200 Greenville DE 19807 lyme vaccine for humans;
LYMIT CONNAUGHT TECHNOLOGY CORPORATION 3711 Kennett Pike, Suite 200 Greenville DE 19807 lyme vaccine for humans;LYME IT;
PROLYME CONNAUGHT TECHNOLOGY CORPORATION 3711 Kennett Pike, Suite 200 Greenville DE 19807 lyme vaccine for humans;
PRYME CONNAUGHT TECHNOLOGY CORPORATION 3711 Kennett Pike, Suite 200 Greenville DE 19807 lyme vaccine for humans;
PRYME CONNAUGHT TECHNOLOGY CORPORATION 3711 Kennett Pike, Suite 200 Greenville DE 19807 lyme vaccine for humans;
SPIROCCINE CONNAUGHT TECHNOLOGY CORPORATION 3711 Kennett Pike, Suite 200 Greenville DE 19807 lyme vaccine for humans;
 

Where the owner name is not linked, that owner no longer owns the brand

    
Technical Examples
  1. A vaccine utilizing purified mutant alpha toxins from Clostridium septicum for humans and animals against infections caused by C septicum. Persons potentially affected by C. septicum infections include colonic cancer patients, diabetics, leukemia patients, and neutropenics. The alpha toxin mutant of the vaccine lacks the toxicity of a native C. septicum alpha toxin. A serum comprising antibodies raised to the alpha toxin mutant is also available for treating humans or animals against C. septicum infections. The serum may be used in a method for conferring passive immunity against C. septicum. Antibodies to the alpha toxin mutant may be used in diagnostic tests or in treatments to clear alpha toxin from bodily fluids. The mutant alpha toxin may be produced by recombinant methods using cDNA encoding the toxin, the cDNA contained for example in a plasmid or host cell.